Your browser doesn't support javascript.
loading
Molecular characterization of pathogenic OTOA gene conversions in hearing loss patients.
Laurent, Sacha; Gehrig, Corinne; Nouspikel, Thierry; Amr, Sami S; Oza, Andrea; Murphy, Elissa; Vannier, Anne; Béna, Frédérique Sloan; Carminho-Rodrigues, Maria Teresa; Blouin, Jean-Louis; Cao Van, Hélène; Abramowicz, Marc; Paoloni-Giacobino, Ariane; Guipponi, Michel.
Affiliation
  • Laurent S; Department of Diagnostic, Genetic Medicine Unit, University Hospitals of Geneva, Geneva, Switzerland.
  • Gehrig C; Department of Diagnostic, Genetic Medicine Unit, University Hospitals of Geneva, Geneva, Switzerland.
  • Nouspikel T; Department of Diagnostic, Genetic Medicine Unit, University Hospitals of Geneva, Geneva, Switzerland.
  • Amr SS; Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine, Cambridge, Massachusetts, USA.
  • Oza A; Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine, Cambridge, Massachusetts, USA.
  • Murphy E; Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine, Cambridge, Massachusetts, USA.
  • Vannier A; Department of Diagnostic, Genetic Medicine Unit, University Hospitals of Geneva, Geneva, Switzerland.
  • Béna FS; Department of Diagnostic, Genetic Medicine Unit, University Hospitals of Geneva, Geneva, Switzerland.
  • Carminho-Rodrigues MT; Department of Genetic Medicine and Development, University of Geneva Medical School, Geneva, Switzerland.
  • Blouin JL; Department of Diagnostic, Genetic Medicine Unit, University Hospitals of Geneva, Geneva, Switzerland.
  • Cao Van H; Department of Diagnostic, Genetic Medicine Unit, University Hospitals of Geneva, Geneva, Switzerland.
  • Abramowicz M; Department of Genetic Medicine and Development, University of Geneva Medical School, Geneva, Switzerland.
  • Paoloni-Giacobino A; Department of Otorhinolaryngology, Head and Neck Surgery, Pediatric Otolaryngology Unit, University Hospitals of Geneva, Geneva, Switzerland.
  • Guipponi M; Department of Diagnostic, Genetic Medicine Unit, University Hospitals of Geneva, Geneva, Switzerland.
Hum Mutat ; 42(4): 373-377, 2021 04.
Article in En | MEDLINE | ID: mdl-33492714
ABSTRACT
Bi-allelic loss-of-function variants of OTOA are a well-known cause of moderate-to-severe hearing loss. Whereas non-allelic homologous recombination-mediated deletions of the gene are well known, gene conversions to pseudogene OTOAP1 have been reported in the literature but never fully described nor their pathogenicity assessed. Here, we report two unrelated patients with moderate hearing-loss, who were compound heterozygotes for a converted allele and a deletion of OTOA. The conversions were initially detected through sequencing depths anomalies at the OTOA locus after exome sequencing, then confirmed with long range polymerase chain reactions. Both conversions lead to loss-of-function by introducing a premature stop codon in exon 22 (p.Glu787*). Using genomic alignments and long read nanopore sequencing, we found that the two probands carry stretches of converted DNA of widely different lengths (at least 9 kbp and around 900 bp, respectively).
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Deafness / GPI-Linked Proteins / Hearing Loss Limits: Humans Language: En Journal: Hum Mutat Year: 2021 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Deafness / GPI-Linked Proteins / Hearing Loss Limits: Humans Language: En Journal: Hum Mutat Year: 2021 Document type: Article